Is a prominent vaccine denier the best pick for Health & Human Services? | Letters
The importance of heeding medical science; worry over Trump's executive order against refugee admissions; tax cuts; and more.
Respiratory Diagnostics Market to Hit USD 9.02 Billion by 2030 with 6.5% CAGR | MarketsandMarkets™
The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ 6.17 billion in 2024 and an impressive US$ 9.02 billion by ...
PipelineReview.com5h
U.S. FDA approves Celltrion’s AVTOZMA® (tocilizumab-anoh), a biosimilar to ACTEMRA®
JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...